Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EQUAM: Impact of Ovarian Stimulation With hMG on Embryo Quality
NCT07691073Phase 4Not yet recruiting
- Sponsor
- Fundación Dexeus Mujer
- Start
- Sep 2026
- Primary completion
- Feb 2029
- Countries
- 1
01
Overview
A Phase 4 trial of follitropin delta, human menopausal gonadotrophin in infertility, sponsored by Fundación Dexeus Mujer. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
follitropin deltahuman menopausal gonadotrophin
03
Conditions
infertility
Beyond the preview
Go deeper on NCT07691073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07691073.